Tag: Product Development
Opportunity To Develop Nerve Agent Antidote At Scale From Human Umbilical Cord Cells
Aurora BioSolutions Inc. and Tissue Regeneration Therapeutics Inc. (TRT) have announced that they have discovered that human umbilical cord cells are a sustainable source of human butyrylcholinesterase (HuBChE), a bioscavenger that neutralizes organophosphate nerve toxins. Furthermore, the cells can...
FDA Clearance For Cesca Therapeutics’ Automated Cord Blood Stem Cell Collection Solution
Cesca Therapeutics Inc., has announced that its device subsidiary, ThermoGenesis® Corp., has received 510(k) clearance from the U.S. Food & Drug Administration (FDA) for its proprietary AXP® II AutoXpress® Platform (AXP II) for clinical blood banking.
Cesca Therapeutics Inc., founded...
Hitachi Chemical Advanced Therapeutics Solutions Increases Stake In Counter-Flow Centrifugation
Caladrius Biosciences, Inc. is a clinical stage biopharmaceutical company with multiple technology platforms including cell therapies targeting select cardiovascular indications and autoimmune diseases.
Invetech Pty Ltd., is a full-service provider of product design, instrument development and contract manufacturing with a...
